Skip to main content
Equibles
IMUX logo

IMUX · Immunic, Inc.

Track IMUX — free

Use IMUX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about IMUX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.06 -0.52 (-3.14%) At close · Aug 14
Market Cap
$219.13M
Shares
13.64M

Immunic, Inc. Earnings Call Transcripts

Every quarterly earnings call for Immunic, Inc. (IMUX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-11
Immunic, Inc. Q2 FY2026 Earnings Call
Diluted EPS
$-0.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Immunic, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-1.08
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-11-07
Immunic, Inc. Q3 FY2024 Earnings Call
Confident tone Vidofludimus calcium lead asset in MS Phase 2 CALLIPER trial in progressive MS Post COVID Syndrome / RAPID_REVIVE trial
Diluted EPS
$-2.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Immunic, Inc. Q2 FY2024 Earnings Call
Diluted EPS
$-2.10
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Immunic, Inc. Q1 FY2024 Earnings Call
Confident tone Vidofludimus calcium in multiple sclerosis Neurofilament light chain (NfL) biomarker Neuroprotective mechanism / Nurr1
Diluted EPS
$-3.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Immunic, Inc. Q4 FY2023 Earnings Call
Confident tone Vidofludimus calcium in progressive MS (CALLIPER) Vidofludimus calcium in relapsing MS (ENSURE Phase III) IMU-856 in celiac disease
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Immunic, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-5.10
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Immunic, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-5.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Immunic, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-5.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Immunic, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Immunic, Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-6.90
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Immunic, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-7.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Immunic, Inc. Q1 FY2022 Earnings Call
Diluted EPS
$-7.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Immunic, Inc. Q4 FY2021 Earnings Call
Diluted EPS
$-8.10
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Immunic, Inc. Q3 FY2021 Earnings Call
Diluted EPS
$-7.60
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Immunic, Inc. Q2 FY2020 Earnings Call
Diluted EPS
$-9.00
Audio Transcript Slides 8-K10-Q
Showing 1–16 of 16 earnings calls
Key facts CIK 1280776 CUSIP 4525EP200 13F (30d) 60 filings 58 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)